Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives
Immune-mediated inflammation plays a major role in atherosclerosis and atherothrombosis, two essential features for cardiovascular disease (CVD) development, currently considered as the leading cause of death in the western world. There is accumulating evidence showing that humoral autoimmunity migh...
Main Authors: | P. C. Teixeira, P. Cutler, N. Vuilleumier |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/868251 |
Similar Items
-
Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
by: Josephine L.C. Anderson, et al.
Published: (2019-06-01) -
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
by: Sabrina Pagano, et al.
Published: (2015-01-01) -
Apolipoprotein E and cardiovascular disease
by: Adriana Moreno Valladares, et al.
Published: (2006-01-01) -
Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
by: Wei-Ling Chen, et al.
Published: (2021-08-01) -
Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1
by: Oravec Milan, et al.
Published: (2011-06-01)